Atherosclerotic Progression Is Related to Immune-Related Adverse Events

Lung cancer

(2021) Alesha A Thai et al.   LANCET

Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling

(2020) Wenzheng Xia et al.   Cell Death & Disease

Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

(2020) Florian Moik et al.   BLOOD

Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque

(2020) Zsofia D. Drobni et al.   CIRCULATION

Spectrum and impact of checkpoint inhibitor-induced irAEs

(2020) Laura C. Cappelli et al.   Nature Reviews Rheumatology

DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis

(2019) Run-Ze Tang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Comparison of Atherosclerotic Calcification in Major Vessel Beds on the Risk of All-Cause and Cause-Specific MortalityCLINICAL PERSPECTIVE

(2015) Daniel Bos et al.   Circulation-Cardiovascular Imaging

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

(2015) Ahmad A. Tarhini et al.   Journal for ImmunoTherapy of Cancer

Calcifications of the Thoracic Aorta on Extended Non-Contrast-Enhanced Cardiac CT

(2014) Damian Craiem et al.   PLoS One

Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation

(2011) De-xiu Bu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY